Skip to content

Safety and Exploratory Efficacy Study of UCMSCs in Patients With Fracture and Bone Nonunion

Status
UNKNOWN
Phases
Phase 1Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02815423
Enrollment
40
Registered
2016-06-28
Start date
2017-01-31
Completion date
2020-01-31
Last updated
2016-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bone Nonunion, Fracture

Brief summary

The purpose of the present study is to evaluate the safety and exploratory efficacy of the umbilical cord mesenchymal stem cells for patients with fracture and bone nonunion.

Interventions

BIOLOGICALUCMSCs

Transplatation of umbilical cord mesenchymal stem cells

BIOLOGICALPercutaneous

Percutaneous injection

Sponsors

Guangzhou Panyu Central Hospital
CollaboratorOTHER
South China Research Center for Stem Cell and Regenerative Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Every patient with non union in the site of bone fracture and nonunion. * Age more than 18 and less than 60 years old. * Nonunion or delayed union.

Exclusion criteria

* Diagnosis of cancer. * Pregnancy or breastfeeding. * Patient positive by serology or PCR for HIV, hepatitis B or C infection the patient with Accompanied fracture such as hip fracture that could not weight bearing. * Any medical or psychiatric condition that in the researcher´s opinion could affect the patient´s ability to complete the trial or hamper the participation in the trial. * Patients do not sign the consent forms

Design outcomes

Primary

MeasureTime frameDescription
Radiological progression of bone fusion12 monthsAfter patients receiving mesenchymal stem cells or placebo, imaging control by X-ray and CT, and then analysis by software(ImageJ ) at 1, 6 and 12 months

Secondary

MeasureTime frame
Comparison of the rate of complications between the 2 groups12 months
Incidence of increased temperature sensitivity by questionnaire6 months
Incidence and severity of infections at grafting sites by questionnaire6 months

Contacts

Primary ContactXuetao Pei, M.D., Ph.D
AMMS0906@163.com8610-68164807
Backup ContactSihan Wang, Ph.D
wangsihan@scrm.org.cn8620-89199011

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026